Literature DB >> 28579160

Complex Energy Metabolic Changes in Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction.

Kirstie A De Jong1, Gary D Lopaschuk2.   

Abstract

Alterations in cardiac energy metabolism contribute to the severity of heart failure. However, the energy metabolic changes that occur in heart failure are complex, and are dependent not only on the severity and type of heart failure present, but also on the coexistence of common comorbidities such as obesity and type 2 diabetes. In this article we review the cardiac energy metabolic changes that occur in heart failure. An emphasis is made on distinguishing the differences in cardiac energy metabolism between heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF) and in clarifying the common misconceptions surrounding the fate of fatty acids and glucose in the failing heart. The major key points from this article are: (1) mitochondrial oxidative capacity is reduced in HFpEF and HFrEF; (2) fatty acid oxidation is increased in HFpEF and reduced in HFrEF (however, oxidative metabolism of fatty acids in HFrEF still exceeds that of glucose); (3) glucose oxidation is decreased in HFpEF and HFrEF; (4) there is an uncoupling between glucose uptake and oxidation in HFpEF and HFrEF, resulting in an increased rate of glycolysis; (5) ketone body oxidation is increased in HFrEF, which might further reduce fatty acid and glucose oxidation; and finally, (6) branched chain amino acid oxidation is impaired in HFrEF. The understanding of these changes in cardiac energy metabolism in heart failure are essential to allow the development of metabolic modulators in the treatment of heart failure.
Copyright © 2017 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28579160     DOI: 10.1016/j.cjca.2017.03.009

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  43 in total

1.  Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.

Authors:  Senthil Selvaraj; Daniel P Kelly; Kenneth B Margulies
Journal:  Circulation       Date:  2020-06-01       Impact factor: 29.690

2.  Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency.

Authors:  Kim L Ho; Liyan Zhang; Cory Wagg; Rami Al Batran; Keshav Gopal; Jody Levasseur; Teresa Leone; Jason R B Dyck; John R Ussher; Deborah M Muoio; Daniel P Kelly; Gary D Lopaschuk
Journal:  Cardiovasc Res       Date:  2019-09-01       Impact factor: 10.787

3.  Application value of myocardial work technology by non-invasive echocardiography in evaluating left ventricular function in patients with chronic heart failure.

Authors:  Qiang Zheng; Lin Liu; Yanan Li; Cunying Cui; Yuanyuan Liu; Yanbin Hu; Danqing Huang; Ying Wang; Jun Liu
Journal:  Quant Imaging Med Surg       Date:  2022-01

4.  Exploration of the amino acid metabolic signature in anthracycline-induced cardiotoxicity using an optimized targeted metabolomics approach based on UPLC-MS/MS.

Authors:  Wendi Li; Shanshan Li; Zhenju Cao; Yi Sun; Wei Qiu; Mei Jia; Ming Su
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-07-26       Impact factor: 3.195

5.  Functional and Metabolic Imaging in Heart Failure with Preserved Ejection Fraction: Promises, Challenges, and Clinical Utility.

Authors:  Matthew K Burrage; Andrew J Lewis; Jack J J Miller
Journal:  Cardiovasc Drugs Ther       Date:  2022-07-26       Impact factor: 3.947

6.  Branched Chain Amino Acids.

Authors:  Michael Neinast; Danielle Murashige; Zoltan Arany
Journal:  Annu Rev Physiol       Date:  2018-11-28       Impact factor: 19.318

Review 7.  Mechanisms underlying the pathophysiology of heart failure with preserved ejection fraction: the tip of the iceberg.

Authors:  Daniela Miranda-Silva; Tânia Lima; Patrícia Rodrigues; Adelino Leite-Moreira; Inês Falcão-Pires
Journal:  Heart Fail Rev       Date:  2021-01-07       Impact factor: 4.214

8.  Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart Failure.

Authors:  Gizem Keceli; Ashish Gupta; Joevin Sourdon; Refaat Gabr; Michael Schär; Swati Dey; Carlo G Tocchetti; Annina Stuber; Jacopo Agrimi; Yi Zhang; Michelle Leppo; Charles Steenbergen; Shenghan Lai; Lisa R Yanek; Brian O'Rourke; Gary Gerstenblith; Paul A Bottomley; Yibin Wang; Nazareno Paolocci; Robert G Weiss
Journal:  Circ Res       Date:  2022-02-03       Impact factor: 17.367

9.  MicroRNA-195 Regulates Metabolism in Failing Myocardium Via Alterations in Sirtuin 3 Expression and Mitochondrial Protein Acetylation.

Authors:  Xiaokan Zhang; Ruiping Ji; Xianghai Liao; Estibaliz Castillero; Peter J Kennel; Danielle L Brunjes; Marcus Franz; Sven Möbius-Winkler; Konstantinos Drosatos; Isaac George; Emily I Chen; Paolo C Colombo; P Christian Schulze
Journal:  Circulation       Date:  2018-01-12       Impact factor: 29.690

Review 10.  Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.

Authors:  Dianne M Perez
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.